Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever by unknown
EVIDENCE FOR TWO DISTINCT CLASSES OF
STREPTOCOCCAL M PROTEIN AND THEIR
RELATIONSHIP TO RHEUMATIC FEVER
BY DEBRA BESSEN, KEVIN F. JONES, AND VINCENT A. FISCHETTI
From The Rockefeller University, New York, New York 10021
Group A streptococci are human pathogens that infect primarily at the skin or
nasopharyngeal mucosa. A major virulence factor present on the streptococcal sur-
face is Mprotein, a molecule ofwhich there exists more than 80 distinct serological
types. M protein provides the streptococcus with the ability to resist phagocytosis
by polymorphonuclear leukocytes, and only antibodies directed to type-specific de-
terminants permit opsonophagocytosis in whole blood (1, 2). Structural studies re-
veal that M protein is composed of two a-helical polypeptide chains that give rise
to a coiled-coil, fibrillar structure extending -60 nm from the cell surface (3, 4).
The antigenically variable determinants of type specificity are located in the NH2-
terminal portion ofthe molecule, distal to the cell wall (2, 5). Some epitopes ofthe
Mprotein molecule are shared amongdifferent Mserotypes, and thedegree ofrelat-
edness increases at sites closer to the COOH terminus (6, 7).
Recent progress towards a group A streptococcal vaccine indicates that mucosal
immunization withshared immunodeterminants ofMprotein leads to reduced pha-
ryngeal colonizationin amousemodel(8). To better define those epitopes forpoten-
tial use in a non-type-specific-based vaccine, we sought to gain amoredetailed un-
derstanding ofthe antigenic relatedness of surface-exposed portions of M protein
among isolates ofthe same serotype, and between isolates of distinct serotypes. In
this report, we describe an antigenicallyconserved domain within the surface-exposed
portion of Mprotein ofcertain serological types, and provide evidence for two dis-
tinct classes ofMprotein molecules based on the presence or absence ofthis anti-
genic domain.
Acute rheumatic fever (ARF)' is one complication that can follow a nasopharyn-
geal streptococcal infection, and epidemiological studies point to a strong associa-
tionbetween streptococci ofcertainserological Mtypes and ARFattacks(9). Defining
a particular serotype as "rheumatogenic" is not entirely clearcut since pharyngitis
generally precedes the onset of ARF by 3-4 wk and thus, there is uncertainty as
to whether the streptococcus isolated at the time of an ARF attack is ofthe same
lineageasthat which caused pharyngitis. Nevertheless, itis apparent that streptococci
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of certain M types are often associated with ARF outbreaks, whereas other sero-
types are rarely seen in association with this disease. The following M types have
been associated with one or more major outbreaks of ARE: M1, M3, M5, M6, Mll,
M12, M14, M17, M18, M19, M24, M27, M29, M30, M32, and M41 (9-12). The
second finding ofthis report is that streptococcal serotypes expressing the conserved
antigenic domain ofM protein include those associatedwith outbreaks of ARF, sug-
gesting that the two M protein classes of group A streptococci may differ in their
virulence properties.
Correlations can be made between particular M serotypes and otherphysicochemical
properties of group A streptococci. M-associated protein (MAP) was identified in
the 1970s as a surface component of M protein-bearing organisms that co-purifies
with the type-specific substance (10, 13, 14). Isolates of most M serotypes readily
fall into one of two antigenic MAP groups (I and II), based on test antisera reactive
with one group and not the other (10, 14). At the time MAP antigens were charac-
terized, the definition of M protein was limited to that of a type-specific substance
with antiphagocytic properties, and the existence of immunodeterminants shared
among different M types was not known for certain. Therefore, crossreactive mate-
rial that co-purified with M protein was usually considered to be distinct from the
M protein molecule. Serotypes of the MAP I group include most M types associated
with ARF plus several serotypes associated with pyoderma, and the serum of ARF
patients contains elevated complement-fixing activity to MAP I antigen. MAP II
serotypes include both pyoderma and nasopharyngeal serotypes, and typically pro-
duce opacity when cultivated in horse serum (the serum opacity reaction is a result
of lipoprotein cleavage) (10). Thus, there is a strong correlation between MAP II
antigens and opacity factor (OF) production, and between MAP I antigens and M
serotypes associatedwith ARE However, the biochemical composition of MAP an-
tigens and OF remained largely undefined.
Using a panel of seven antibodies directed to well-defined antigenic sites within
the M6 protein molecule, we analyzed the presence of surface-exposed epitopes on
138 streptococcal isolates representing more than 50 different M types. The data
revealed a striking correlation between those serotypes possessing an antigenically
conserved surface-exposeddomain, and those serotypes previously described as having
MAP I antigen (10). Included in the group that share a conserved domain with M6
protein are the ARRassociated serotypes. Furthermore, most isolates that lack the
conserved domain on their surface give a positive serum opacity reaction, whereas
nearly all isolates possessing the conserved domain fail to produce OF. Based on
these fundamental differences, we propose that most group A streptococcal sero-
types fall into one of two major classes of M protein, which parallel the MAP I and
II antigenic types.
Materials and Methods
Bacterial Strains.
￿
Streptococci were from The Rockefeller University collection. With few
exceptions, organisms used for experiments had been passaged in the laboratory no more
than five times after the original isolation. All strains were previously characterized according
to group carbohydrate and M type by Dr. R. C . Lancefield and co-workers (1).
Heat-killed Streptococci.
￿
Overnight streptococcal cultures grown in Todd-Hewitt broth were
centrifuged, washed in saline, heat killed for 30 min at 56°C, and allowed to cool slowly to
room temperature. Cultures were centrifuged, pellets were concentrated in PBS containing
1% acidified BSA to an OD65o equivalent to 5 .0, and they were stored at 4°C .BESSEN ET AL.
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Antibody Preparation and Titration.
￿
Antisera were raised in rabbits to synthetic peptides cor-
responding to residues 121-145, 140-158, 216-235, and 248-269 of M6 protein from strain
D471 (Fig. 1, Table I) (2). Affinity-purified antibody was prepared by absorption of antisera
to the corresponding peptide covalently linked to glutardialdehyde glass beads (2, 8), and
were stored in 1°jo BSA at -80°C. mAbs 10A11, 1OB6, and 1OF5 have been previously de-
scribed (6, 15).
The concentration of monospecific antipeptide antibody and mAb giving half-maximal
immunoreactivity to ColiM6 antigen (the product of the emm-6.1 gene cloned in Escherichia
cola) (16) was established by kinetic ELISA (k-ELISA) (17). Microtiter wells were coated with
antigen (5 ug/ml), antibody was diluted twofold and incubated for 3 h at 25°C in 20 mM
phosphate, pH 7.2/0.5 M NaCI/0.25% Brij, wells were washed, and they were incubated
for 2 h with alkaline phosphatase-conjugated secondary antibody. Absorbance (405 nm) was
recorded at 4-min intervals at room temperature with intermittent shaking on an ELIDA-5
reader (Physica Inc., New York, NY) programmed to calculate the kinetics of the enzyme
reaction in individual wells.
Antibody Absorption Assay.
￿
For antibody absorption to whole streptococci, 80 gl of heat-
killed organisms were mixed with 20 dal of affinity-purified antibody or mAb diluted in 1%
BSA-PBS in preblocked V-bottomed microtiter wells to a final antibody concentration giving
half-maximal immunoreactivity to ColiM6 antigen. Plates were sealed, mixed, and rotated
end-over-end overnight at 4°C. Microtiter plates were centrifuged, the supernatants were
removed and mixed 1 :1 with 0.5 % Brij/20 mM phosphate/1 .0 M NaCl, and were transferred
to flat-bottomed microtiter plates that had been precoated with ColiM6 antigen and blocked
with PBS-Brij. Immunoreactivity was measured by k-ELISA (described above), and all mea-
surements were performed in triplicate. The percentage of antibody bound to heat-killed
streptococci was calculated based on control samples devoid of streptococci during absorp-
tion. The proportion of a given antibody that bound to the surface of heat-killed organisms
was scored as follows: 0, <20% bound; +/-, 20-29.9% ; +, 30-59.9% ; ++, 60-84.9% ; and
+++, 85-100%.
To measure nonimmune binding of IgG by Ig binding proteins present on the surface
ofmany group A streptococcal isolates (18), heat-killed organisms were incubated with either
purified mouse myeloma IgG (Sigma Chemical Co., St. Louis, MO) or rabbit serum IgG
(Cappel Laboratories, Malvern, PA) as described above. The amount of unabsorbed anti-
body was measured by capture k-ELISA using wells coated with anti-mouse IgG (Cappel
Laboratories) or anti-rabbit IgG (Pel-Freeze Biologicals, Rogers, AR) affinity-purified anti-
body. Two streptococcal isolates tested bound 15% or more of mouse IgG by a nonimmune
mechanism and therefore were excluded from these studies. Streptococci that bound 15%
or more of rabbit IgG were scored positive (+) for IgG binding protein (IgGBP). Absorption
of anti-M protein mAbs was measured for all streptococcal isolates. Anti-M protein rabbit
antibody was tested only for those isolates that bound <15% of rabbit IgG by a nonimmune
mechanism.
Serum Opacity Reaction.
￿
Heat-inactivated horse serum (Sigma Chemical Co.) was mixed
3:1 with Todd-Hewitt broth and inoculated with a loopful ofstreptococcal stock cultures (19).
Organisms were incubated 18-24 h at 37°C, centrifuged, and the OD475 ofthe supernatant
was measured. Cultures giving OD475 >0.500 were considered to be positive (+) for serum
opacity reaction; values <0.200 were considered negative (-); cultures giving values between
0.200 and 0.500 were scored as +/-.
MProtein Extraction and Western BlotAnalysis.
￿
M protein extracts were prepared from over-
night broth cultures of streptococci using bacteriophage lysin as previously described (20).
Lysin extracts were subjected to SDS-PAGE, electrotransferred to nitrocellulose, incubated
with mAbs or anti-ColiM6 human Ig followed by alkaline phosphatase-conjugated secondary
antibodies, and developed (20). Anti-ColiM6 Ig was prepared from human serum that had
been affinity purified to ColiM6 linked to glutardialdehyde beads (2).
Results
Antibody Probes.
￿
The M6 protein molecule of strain D471 contains three major
regions (A, B, and C) of repeated sequence segments (4, 21) (Fig. 1). High frequency,272
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intragenic recombinational events between reiterated DNA sequenceswithin the struc-
tural gene encoding M protein can lead to deletion or duplication of one or more
repeat blocks, and recombination between inexact repeats within the A, B, or C
repeat regions can give rise to mutations in the amino acid sequence and antigenic
structure (21, 22). The NH2-terminal nonrepeat region and the A repeat block of
M6 protein contain determinants of type specificity (2, 7). Surface-exposed im-
munodeterminants located in the B and C repeat regions ofM6 protein are shared
among different M serotypes (2, 6).
The antibody probes used for antigenic analysis are directed to antigenic sites
within the B and C repeat regions of the M6 protein molecule of strain D471 (Fig.
1, Table I). Anti-peptide rabbit serum was affinitypurified to synthetic peptides cor-
respondingin sequence to B repeat residues 121-145 (probe IIIB) and 140-158 (IIB),
residues 216-235 which flank the pepsin-susceptible site (PS), and C repeat residues
248-269 (IC) ofthe D471 M6 molecule. Epitopes ofthe mAb probes have been pre-
viously localized to B repeat residues 134-139 (IB; 10A11), and to C repeat residues
275-289 (IIC and IIIC; 1OF5 and 1OB6, respectively) (15). Complete and partial
repeated segments ofsix ofthe seven epitopes found elsewhere in the D471 M6 mol-
ecule are indicated.
Surface-exposed Epitopes and Opacity Factor Production.
￿
Between one and six strep-
tococcal isolates ofmost serological types among types Ml through M67, plus sev-
eral nontypable (NT) isolates, were examined by the antibody absorption assay for
the presence ofsurface-exposedantigenic epitopes shared with M6strain D471 (Table
II). Rabbit antibody probes (IIB, IIIB, PS, IC) were nottested forisolates thatbound
>,15% of rabbit IgG by a nonimmune mechanism. One or more B repeat probes
gave strong immunoreactivity (+ + or + + +) to all isolates ofserotypes M6, M5,
M14, M19, and M36 (Table II A). At least one of the three C repeat probes tested
reacted strongly with isolates representing approximately half ofthe serotypes ex-
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Region and domain assignments of the M6 protein of strain D471. Repeat regions
A, B, C, andD are composed of tandemly repeatingsequence sub-blocks that differ in sequence
and length foreach region. Region A is composed of 5 direct tandem repeats of 14 aminoacids
each, region Bcontains 5 tandem repeats of 25 residues each, andregion C contains 2.5 repeats
of 42 amino acids. Repeat blocks slightly divergent from the consensus repeat blocks are indi-
cated by shading. The non-surface-exposed, cell-associated region begins at residue 298 (30).
Pro/Gly is theproline andglycine-rich region located in thecell wall, andthemembrane anchor
is composed of 19 amino acids adjacent to a short charged tail. Pepsin designates the position
of the pepsin sensitive site between residues 228 and 229. The molecular weight of the D471
M6 protein monomer is calculated to be -49,000, andthe molecule is 441 amino acidsin length.
Locations of antibody probes (Table I), and complete and partial repeats are indicated.Q w
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TABLE II
Surface-exposed Antigenic Epitopes and Opacity Factor Production
Type
￿
Strain Site Date IgGBP IB
￿
IIB
￿
IIIB
￿
PS
￿
IC
￿
IIC
￿
IIIC
￿
OF
continued
A. Isolates sharing B and C repeat region epitopes
M6 D471 ? 1971 - +++ +++ +++ +++ +++ +++ +++
1RP112 NP 1952 - ++ + ++ +++ ++ +++ ++
1RP178 NP 1955 - ++ + ++ +++ +++ +++ +++
MOIO15 NP 1986 - ++ ++ + ++ ++ +++ ++
4RS103 NP 1942 - ++ + ++ +++ +++ +++ +++
M5 B788 NP 1982 - +++ +++ ++ ++ + +++ +++
1RP144 NP 1953 - +++ ++ + ++ + +++ +++
2RP19T NP 1946 - +++ + + ++ + +++ +++
2RP143 NP 1953 - ++ + + ++ + +++ +++
M14 D469 ? 1971 - ++ ++ + + +++ +++ +++
4RP106 NP 1951 - + +++ + ++ +++ +++ +++
25RS84 NP 1942 - ++ +++ + ++ +++ +++ +++
D773 NP 1974 - +++ + + + ++ +++ +++
M19 1GL205 NP 1946 - ++ + 0 + ++ +++ +++
1RP43 NP 1948 - ++ + 0 + ++ +++ +++
1RP97 NP 1951 - ++ + 0 + ++ +++ +++
D709 NP 1973 - ++ + 0 + ++ +++ +++
M36 A457 ? 1961 + +++ +++ +++
NT 1RP257 NP 1962 - + + + 0 + + + + + + + + +
B. Isolates sharing C repeat region epitopes only
M1 D710 ? 1973 + 0 +++ +++
1GL100 NP 1946 + 0 + + + + +
3RP215 NP 1958 + 0 + + + + + +
M3 D922 ? 1975 - 0 0 0 0 + + + + + + +
1 RP99 NP 1951 + 0 + + + + +
2GL215 NP 1946 - 0 0 0 0 + + + + +
979-88 NP 1988 + 0 + + + + +
M4 D896 NP 1975 - 0 0 0 0 + + + + + + /-
C240 NP 1942 - 0 0 0 0 +/- + + + +
M8 D784 SK 1974 - 0 0 0 + / - + + + 0
M12 A735 NP 1964 - 0 0 0 0 + + + + + + +
2RP196 NP 1956 - 0 0 0 0 + + + + +
A374 NP 1960 - 0 0 0 0 + + + + + + +
M17 1GL12 NP 1946 - 0 0 0 0 + + + + +/-
J17E/165 NP 1932 - 0 0 0 0 + + + + + +
1RSC 150 NP 1943 - 0 0 0 0 + + + + +/-
M18 1RP268 NP 1963 + 0 + + + + + +
1RP38 NP 1948 + 0 + + + + + +
1RP68 NP 1949 + 0 + + + + + +
1RP110 NP 1952 + 0 + + + + + +
986-88 NP 1988 - 0 0 0 0 + + + + + +
M23 1RP62 NP 1949 - 0 0 0 0 + + + + + + + +
19RS17 NP 1943 + 0 + + + + + +
M24 22RS72 NP 1941 - 0 0 0 0 + 0 + +
1 RP284 NP 1964 - 0 0 0 0 + 0 + + +
1RSC165 NP 1942 - 0 0 0 0 + 0 + + +
M26 11RS100 NP 1942 - 0 0 0 0 + + + + + + +
M27 A910 NP 1966 - 0 0 0 0 +++ +++ +++
M28R D685 NP 1972 + 0 + + + + +BESSEN ET AL.
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continued
Type Strain Site Date IgGBP
TABLE
IB
II
IIB
(continued)
IIIB PS IC IIC HIC OF
M29 D470 ? 1971 - 0 0 0 0 + + + + + + + -
3RP70 NP 1949 - 0 0 0 0 + + + + + + + -
4RS68 NP 1941 - 0 0 0 0 + + + + + + -
M30 1GL120 NP 1946 - 0 0 0 0 + + + + + + + -
1RP31 NP 1947 - 0 0 0 0 + + + + + + + -
D617 SK 1972 + 0 + + + + + + -
M32 10RS101 NP 1942 + 0 + + + + + + -
D641 SK 1972 + 0 + + + + + + -
M33 A984 NP 1968 + 0 + + + + + + -
13RS60 NP 1941 - 0 0 0 0 +++ +++ +++ -
D323 BL 1969 + 0 + + + + + + -
M37 D466 ? 1971 - 0 0 + / - 0 + + + + + 0 -
M38 2RSC3 NP 1942 + 0 + + + + + + -
M41 D463 ? 1971 - 0 0 0 0 + 0 + + -
D421 SK 1971 + 0 + + + + + + / -
M43 C506 NP 1943 + 0 + + + + + + -
D821 SK 1975 + 0 + + + + + + -
M46 A837 SK 1965 + 0 + + 0 -
M48 D493 ? 1971 + 0 + + + + + + -
M52 A889 ? 1966 + 0 + + + + + + -
D680 NP 1972 + 0 + + + + + + -
M53 D948 SK 1976 - 0 0 0 0 + + + + + + + + + -
M54 D432 ? 1971 + 0 + + + + + -
M55 D442 ? 1971 + 0 + + + + + + -
M56 D633 SK 1972 + 0 + + + + + + -
R67 SK 1967 + 0 + + + + + + -
M57 D306 ? 1968 - 0 0 0 0 + + + + + + + + + -
M58 D998 ? 1976 - 0 0 0 0 + + + + + + + + + -
M59 D997 ? 1976 + 0 + + + 0 -
NT D735 SK 1973 - 0 0 0 0 + + + + + + + + + -
3RP126 NP 1952 - 0 0 0 0 + + + + + + -
C. Opacity factor producing isolates
M2 D444 ? 1971 + 0 + + 0 +
1RP256 NP 1962 + 0 +/- 0 +
IORS57 ? 1941 + 0 0 0 +
6ORS84 ? 1947 + 0 0 0 +
B344 NP 1950 + 0 0 0 +
29RP112 NP 1952 + 0 0 0 +
M4 2RP113 SK 1952 - 0 + + 0 +
B967 SK 1958 + 0 + 0 +
B512 UR 1953 - 0 0 +/- 0 0 0 0 +
B775 ? 1956 - 0 0 0 0 0 0 0 +
M9 D339 ? 1970 + 0 0 0 +
D995 ? 1976 + 0 0 0 +
1RP278 NP 1964 + 0 0 0 +
Mll A658 ? 1963 + 0 0 0 +
D691 NP 1972 - 0 0 0 0 0 + 0 +
B887 ? 1956 - 0 0 0 0 0 + 0 +
A410 ? 1960 - 0 0 0 0 0 + 0 +
B518 ? 1953 + 0 + 0 +276
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The original site of isolation is indicated as follows: NP, nasopharyngeal; SK, skin (including wound infec-
tions); BL, blood; UR, urine ; ?, site unknown . All isolates are derived from humans, with the exception
of the M50 strain (mo, mouse). The date of isolation is indicated and all isolates of a given M type were
isolated from different individuals at intervals exceeding one year, with few exceptions. The proportion of
an antibody probe that bound to the streptococcal surface was scored: 0, <20 % bound; + / - , 20-29.9 % ;
+, 30-59.9% ; + +, 60-84.9% ; and + + +, 85-100% . Rabbit antibody probes IIB, IIC, PS, and IC were
not tested for isolates that bound 315% of rabbit IgG by a nonimmune mechanism (IgGBP) . Isolates were
scored positive ( + ) or negative ( - ) for IgGBP and for OF production as described in Materials and Methods.
Type Strain Site Date IgGBP
TABLE
IB
II (continued)
IIB IIIB PS IC IIC IIIC OF
M13 D742 ? 1973 - 0 0 +/- 0 0 +/- 0 +
D474 ? 1971 - 0 0 0 0 0 0 0 +
M15 D424 BL 1971 + 0 0 0 +
M22 F312 ? 1976 + 0 0 0 +
D734 ? 1975 + 0 0 0 +
B243 ? 1947 + 0 0 0 +
B401 NP 1951 + 0 0 0 +
LOI 174 NP 1962 + 0 0 0 +
M25 D316 SK 1969 + 0 0 0 +
M28R T28/150A ? 1935 - 0 0 0 0 0 0 0 +
D722 NP 1973 + 0 0 0 +
M35 C135 NP 1942 + 0 0 0 +
M40 D733 ? 1973 + 0 0 0 +
M44 C848 NP 1945 + 0 0 0 +
M49 D938 SK 1976 - 0 +/- 0 +/- 0 +/- 0 +
B915 NP 1958 + 0 +/- 0 +
B737 SK 1957 - 0 +/- 0 0 +/- 0 0 +
NZ131 SK - 0 + + 0 + 0 0 +
M51 D976 ? 1976 + 0 0 0 +
M58 D774 SK 1974 + 0 0 0 +
M60 D398 ? 1970 - 0 0 0 0 0 0 0 +
M61 D812 SK 1975 - 0 0 0 0 0 0 0 +
M62 A956 ? 1967 + 0 0 0 +
M63 D459 ? 1971 + 0 + 0 +
M66 D794 ? 1975 + 0 0 0 +
NT 1RP18 SK 1946 + 0 0 0 +
1RP66 NP 1949 + 0 + + 0 +
1RP190A NP 1955 + 0 + 0 +
3RP150 NP 1953 + 0 0 0 +
1RP15 NP 1946 + 0 0 0 +
D. Isolates devoid of opacity factor and C repeat epitopes
M1 1RP94 NP 1951 - 0 0 0 0 0 0 0 -
M31 F376 NP 1980 - 0 0 0 0 0 0 0 -
M34 C 142 ? 1942 - 0 0 0 0 0 0 0 -
M39 D869 NP 1975 + 0 0 0 -
19RS14 NP 1941 - 0 0 0 0 0 +/- 0 -
M42 1RS79 NP 1979 - 0 0 0 0 0 0 0 -
M47 C716 ? 1943 - 0 0 0 0 0 0 0 -
M50 A203 Mo 1959 - 0 0 0 0 0 0 0 + / -
M51 A291 ? 1960 + 0 0 0 -
M65 D793 ? 1975 + 0 0 0 -
M67 D795 ? 1975 - 0 0 0 0 0 0 0 -BESSEN ET AL.
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amined (Table II B) . Furthermore, the antibody probe directed to the pepsin site
region reacted only with isolates that also strongly bound B repeat antibodies. The
proximity of the antigenic epitope of probe PS to that of the C repeat region probes
suggests the presence of an antigenic domain, which is delimited at one end in the
area encompassing both the pepsin-susceptible site and the first C repeat block of
the D471 M6 molecule (Fig. 1).
Many isolates of group A streptococci produce opalescence when cultivated in
the presence of horse serum (19). Ofthe 77 isolates displaying strong reactivity with
probe IIC, only two produced OF (Table III). Similarly, none of the 69 isolates bound
strongly by probe IIIC were OF producers. Thus, isolates sharingasurface-exposed
conserved domain with type 6 streptococci fail to produce OF. 11 of the 138 isolates
studied lacked strong antibody reactivity with all probes andwere OF nonproducers
(Table II D). Conversely, all but two of the 48 OFproducing isolates lacked strong
binding by any of the three C repeat probes tested (Table II C; Table III). The data
strongly suggest that OF is produced almost exclusively by those isolates deficient
in epitopes crossreactive with the C repeat domain of M6 protein.
Rabbit IgG wasbound viaanonimmune mechanismby 67 ofthe 138 streptococcal
isolates tested. Group A streptococci can express Ig bindingproteins with specificity
for a wide variety of isotypes (18). Of the OF-producing isolates, 34 (or 71%) ex-
pressed an IgGBP with specificity for rabbit IgG (Table II C). Of the streptococci
that were bound strongly by C repeat region probes and failed to produce OF, 30
of 79 (38%) displayed IgGBP activity. Thus, OF-producing organisms were nearly
twice as likely to bind rabbit IgG by an Fc receptor. We do notknow whetherisolates
expressing IgG binding activity have antigenic epitopes reactive with probes IIB,
IIIB, PS, and IC .
Antiphagocytic and Type-speck Properties of OFproducing Isolates.
￿
Since most OF
producing streptococci aredevoid of immunoreactivity to the B and C repeat region
probes (Table II C), we sought to determine whether these organisms produced a
type-specific, antiphagocytic molecule by measuring survival afterrotation in human
blood (23). Of eight randomly selected OF-producing isolates lacking C repeat epi-
topes, five exhibited strong survival, two others were partially resistant to phagocy-
TABLE III
Correlation between C Repeat Epitopes and Opacity Factor Production
A
B
Probe
Total
Immunoreactivity isolates
OF production
OF - (%) OF ` (70)
IIC 2 + to 3+ 77 75 (97) 2 (3)
1 + to 3+ 85 75 (88) 10(12)
0 or +/ - 53 15 (28) 38 (72)
IIIC 2 + to 3 + 69 69 (100) 0 (0)
1 + to 3 + 72 72 (100) 0 (0)
0 or +/- 66 18 (27) 48 (73)
OF Total 2 + to 3 + Immuno- 2 + to 3 + Immuno-
production isolates Probe reactivity (%) Probe reactivity (70)
88 IIC 75 (85) IIIC 69 (78)
48 IIC 2 (4) IIIC 0 (0)278
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tosis, and one isolate was completely phagocytosed (data not shown) . The addition
of rabbit serum containing high titers of type-specific antibody to two surviving iso-
lates led to neutralization of the antiphagocytic property of M protein, resulting
in phagocytosis (data not shown) . Thus, the ability of mostOFproducing, C repeat
epitope-negative isolates to survive completely or partially inhuman blood suggests
that the majority express M protein on their surface in a functional form .
Extraction ofMProteinand Western Blot Analysis.
￿
The possibility exists that OF-pro- If
streptococci do in fact expressM protein-containingC repeat region epitopes
shared with M6, except that the M protein epitopes are present in a form inacces-
sible to antibody probes, perhaps due to masking by the cell wall or a noncovalently
bound streptococcal product . To address this possibility, the entireM protein mole-
cule was released from the streptococcal cell wall using a muralytic enzyme . C re-
peat epitope-positive, OF-nonproducer M6 strain D471 and OF-producing, C re-
peat epitope-deficient isolates were compared for the presence ofM protein by Western
blot analysis . When extracts were probed with a combination of antibodies IIC and
IIIC, only the C repeat-bearing isolate D471 displayedM protein immunoreactivity
(Fig . 2 A) . In contrast, human antibody that had been affinity purified to the entire
M6 protein molecule (ColiM6) detected material extracted from all C repeat epi-
tope-deficient streptococci examined (Fig . 2 B) . The immunoreactive material ex-
hibited the multiple banding pattern characteristic ofM protein (20) . The data sug-
gest that C repeat region epitopes common with M6 are absent from both the extracted
and in situ forms of M protein expressed by OF-producing streptococci .
Discussion
The original objective of this study was to gain a more detailed understanding
ofthe antigenic relatedness ofM protein molecules expressed by different streptococcal
isolates . This information is important for the design of a vaccine targeted to highly
conserved antigenic sites ofM protein (8) . The results indicate that the majority
of serotypes associated with ARF outbreaks share a surface-exposed antigenic do-
main that can be localized to the C repeat blocks of type 6 M protein . In addition,
FIGURE 2 .
￿
Western blot immunoanalysis oflysin ex-
tracts ofClass 11 streptococci. (Lane 1) Strain D398
(M60) ; (lane 2) D938 (M49) ; (lane 3) D316 (M25) ;
(lane 4) D691 (Mll) ; (lane 5) D339 (M9) ; and (lane
6) Class I control strain D471 (M6) . Blots were
probed with (A) a combination ofmAbs 1OF5 (probe
IIC) and 1OB6 (probe IIIC), or (B)human antibody
affinity purified on aColiM6 column . Incubation of
control blots with nonimmune rabbit IgG failed to
reveal nonimmunological binding ofIgGby IgGBP
(data not shown) .BESSEN ET AL.
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the data reveal that there are two major classes ofM protein that differ by the pres-
ence or absence of this M6-like, C repeat region domain.
The conserved, C repeat region shared with the fibrillar M6 protein molecule
appears to form an antigenic domain distinct from the adjacent B repeat region.
Evidence in support ofthis antigenic domain includes the proximity of the highly
conserved C repeat region epitopes to the weakly homologous B repeat region and
pepsin-susceptible site (Fig. 1). The B repeat region through residue 230 forms a
moreflexible coiled-coil structure than the C repeat region beginningat residue 231
(4), suggesting that the C repeat region antigenic domain may have unique struc-
tural characteristics aswell. Amino acid sequence identity between maximally aligned
sequences ofM6 and M12 (24) is <27% between residues 121 (first residue ofB re-
peat region block of M6 from D471) and 231, but abruptly increases to 97% com-
plete identity between residues 232 and 298 (extending from the beginning of the
first C repeat sub-block to the perimeter of cell wall; Fig. 1) (data not shown). A
similar pattern ofhomology to M6 protein is observed with the M24 protein (25).
Thelocation ofthe aminoacid sequence homologiesbetween M6 and otherMtypes,
combined with the antigenic analyses presented in this study, strongly suggests that
the NH2-terminal end of the conserved domain lies at the beginning of the first C
repeat block.
The close parallelobserved between those serotypes previously designated ashaving
MAP I antigen (10), and those Mtypes reacting strongly with C repeat region anti-
body probes, provided the impetus to measure OF production by the streptococcal
isolates under study. Those serotypes that share surface-exposed antigenic epitopes
with the C repeat region ofM6 protein andfailto produceOF, and serotypesdeficient
in epitopes crossreactive with the C repeat region but produce OF are summarized
in Table IV. We propose to designate the two major groups of M protein serotypes
as Class I and Class II, respectively, and this classification closely parallels those
serotypes previously designated MAP I and II, respectively (10) (Table IV). It is
likely that the MAP I antigen represents an immunologically crossreactive portion
TABLE IV
55,
66
Class Variable : 58
MAP Variable : 11, 18, 41, 49, 55, 59
A serotype was classified as Class I if >50% of the isolates examined displayed
strong binding to one or more C repeat region probes and failed to produce OF
(probable). Classified serotypes were further designated as highly probable for
that class if at least three isolates were tested and >80% fell into that class .
M serotypes designated as having MAP I and MAP II antigen (or variable) are
adapted from Widdowson (10).
Comparison of Class I and
to MAP I and II
Class I Highly probable: 1, 3, 5, 6, 12,
Probable: 8, 23, 26, 27, 32, 37,
Class
Antigen
14,
38,
II
17,
41,
M
18,
43,
Protein
Serotypes
19,
46,
24,
48,
Serotypes
29,
52,
30,
53,
33
54,
56, 57, 59
MAP 1: 1, 3, 5, 6, 12, 14, 15, 17, 19, 24, 26, 30, 33, 52, 53, 54, 57
Class II Highly probable: 2, 9, 11, 22, 49
Probable: 4, 13, 15, 25, 28R, 35, 40, 44, 51, 60, 61, 62, 63,
MAP II : 2, 4, 9, 13, 22, 25, 28R, 48, 58, 60, 61, 62, 63280
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of Mprotein, specifically the C repeat domain. While little is known of the antige-
nicity or structure of Class II Mproteins or of MAP II antigen, it is apparent that
some immunodeterminants are shared by the extracted forms of Class I and II M
proteins (Fig. 2). Whether the shared antigenic epitopes reside in buried portions
of the M protein molecule remains to be established. The partial amino acid se-
quence currently available foroneClass II Mprotein (M49) reveals weak homology
with M6, except for 7870 identity to a26-residue stretch within the C repeat region
ofM6 (26), possibly explaining the marginal immunoreactivity of M49 isolates with
C repeat region probes (Table II). Of the M protein molecules whose complete DNA
and amino acid sequence is known to date (M5, M6, M12, M24), all four can be
categorized as Class I molecules, and in addition, all exhibit nearly complete iden-
tity to one another in the C repeat domain (24, 25, 27, 28). Perhaps the extensive
antigenic evaluation ofover 50 serotypes presented in this studywas necessary in order
to establish the existence of a second class of M protein molecules.
Nucleic acid hybridization usingDNA probes derived from the emm-6.1 gene has
been performed on several isolates representing Mserotypes (7), whichcan be classified
as I or II according to Table IV. Using a DNA probe corresponding in position
to a portion of the second C repeat sub-block of strain D471 and extending into
the membrane anchor region (Fig. 1), a distinction can be made between Class I
and II serotypes. Hybridization to M28R, M49, and M62 serotypes (Class II) was
observed only under conditions of low stringency, whereas Class I serotypes (Ml,
M5, M6, M12, M19, M24, M30, M55) hybridized under high stringency condi-
tions. Thus, theDNAhybridization findings suggest that theremay be fundamental
differences between Class I and II M protein molecules at the DNA level.
A major question regarding the molecular basis of ARF is concerned with iden-
tifying a unique feature common to ARFassociated streptococci. All M serotypes
that appear to account for the majority of outbreaks of ARF (9-12) express Class
IMprotein, with the possible exception ofM11. To date, heart crossreactive epitopes
contained within M protein molecules have been localized to type-specific and A
and B repeat region immunodeterminants (29). However, the serum of ARF pa-
tients contains elevated levels of-complement-fixing activity specific for the MAP
I antigen, and MAP I antibody is absorbed by human heart tissue (10, 13). Thus,
immunodeterminants within the conserved C repeat region of Class I M proteins
should also be considered as possible candidates for initiating or contributing to the
autoimmune response associated with rheumaticheart disease. GroupA streptococci
bearingClass II Mprotein types can be viewed as natural mutants that are avirulent
in regards to their capacity to initiate ARE Understanding themolecular properties
of ClassII Mproteins, andthe differences betweenClass I and II streptococci, may
provide insight into the molecular basis for rheumatic fever.
Summary
The antigenic relatedness of surface-exposed portions of M protein molecules de-
rived from group A streptococcal isolates representing more than 50 distinct sero-
types was examined. The data indicate that the majority of serotypes fall into two
major classes. Class I M protein molecules share a surface-exposed, antigenic do-
main comprising the C repeat region defined for M6 protein. The C repeat region
ofM6 protein is locatedadjacent to the COOH-terminal side ofthe pepsin-susceptibleBESSEN ET AL.
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site. In contrast, Class I M proteins display considerably less antigenic relatedness
to the B repeat region of M6 protein, which lies immediately NH2-terminal to the
pepsin site. Surface-exposed portions of Class II M proteins lack antigenic epitopes
that define the Class I molecules. Studies in the 1970s demonstrated that M protein
serotypes can be divided into two groups based on both immunoreactivity directed
to an unknown surface antigen (termed M-associated protein) and production of
serum opacity factor. These two groups closely parallel our current definition ofClass
I and Class II serotypes. Both classes retain the antiphagocytic property character-
istic of M protein, and Class 11 M proteins share some immunodeterminants with
Class I M proteins, although the shared determinants do not appear to be exposed
on the streptococcal surface. Nearly all streptococcal serotypes associated with out-
breaks of acute rheumatic fever express M protein of a Class I serotype. Thus, the
surface-exposed, conserved C repeat domain of Class I serotypes may be a virulence
determinant for rheumatic fever.
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